Avacta Therapeutics (AIM: AVCT, ‘Avacta’, ‘the Company’), a clinical stage biopharmaceutical company developing pre|CISION ®, a tumor-activated oncology delivery platform, today announced the ...
As cancer cases continue to rise and combination therapies gain prominence, the global cytotoxic drugs market is set for ...
MindMetre research note highlights exposure of oncology nurses to harmful effects of cytotoxic drugs
Research note from MindMetre questions whether enough is being done to protect nurses who administer cytotoxic chemotherapy drugs against being exposed to – and damaged by - the harmful effect of ...
Cellular changes that appear during melanoma and lead to treatment resistance can be reversed with drugs—potentially opening ...
Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...
Researchers have developed self-assembling peptide nanotubes that deliver doxorubicin directly into the nucleus of ...
Perseus Proteomics Inc. and Ube Corp. have disclosed antibody-drug conjugates (ADCs) comprising antibodies T004b-PGAP-1 targeting human P-cadherin (CDH3) targeting covalently linked to cytotoxic drug ...
Description The goal of the trial was to evaluate treatment with famotidine compared with placebo among patients taking low-dose aspirin. Hypothesis Famotidine would be more effective in preventing ...
Jiangsu Hengrui Pharmaceuticals Co. Ltd.; Shanghai Hengrui Pharmaceutical Co. Ltd. have synthesized antibody-drug conjugates (ADCs) comprising a claudin 6 (CLDN6)-targeting antibody linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback